Allergan fell $1.76 or 1.0 percent, to $168.21. Baxter International Inc. fell$. 56 or. 8 percent, to $72.54. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.41.» Read More
Allergan rose $1.18 or. 7 percent, to $167.30. Baxter International Inc. rose$. 84 or 1.1 percent, to $75.11. Boston Scientific Corp. rose$. 15 or 1.2 percent, to $12.53.
Allergan fell$. 48 or. 3 percent, to $165.65. Baxter International Inc. rose$. 44 or. 6 percent, to $74.71. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.44.
Allergan fell$. 82 or. 5 percent, to $166.12. Baxter International Inc. rose$. 05 or. 1 percent, to $74.27. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.38.
Allergan fell$. 14 or. 1 percent, to $166.80. Baxter International Inc. rose$. 12 or. 2 percent, to $74.34. Johnson& Johnson fell$. 16 or. 2 percent, to $103.89.
Allergan fell$. 75 or. 4 percent, to $166.19. Baxter International Inc. rose$. 04 or. 1 percent, to $74.26. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.25.
Allergan fell$. 06 or percent, to $166.94. Baxter International Inc. rose$. 02 or percent, to $74.22. Boston Scientific Corp. rose$. 31 or 2.6 percent, to $12.32.
Allergan fell$. 34 or. 2 percent, to $166.66. Baxter International Inc. rose$. 40 or. 5 percent, to $74.60. Boston Scientific Corp. rose$. 31 or 2.5 percent, to $12.32.
Allergan fell$. 13 or. 1 percent, to $166.87. Baxter International Inc. rose$. 06 or. 1 percent, to $74.26. Boston Scientific Corp. rose$. 14 or 1.2 percent, to $12.15.
SHANGHAI, Sept 4- A Chinese anti-monopoly team visited medical devices and semi-conductor firms in Shanghai at the start of September, the country's Ministry of Commerce said in a statement on Thursday, without making clear the purpose of the visit.
Sept 2- General Electric Co's healthcare unit last week won U.S. Food and Drug Administration approval for its mammography device that produces three-dimensional images to detect breast cancer. Hologic Inc came up with one of the first 3- D breast imaging devices in 2001, which continues to dominate the market.
BARCELONA, Sept 1- A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.
BARCELONA, Aug 31- Swiss engineers, famous for making the world's finest watches, are turning their hands to cardiology with a prototype battery-less pacemaker based on a self-winding wristwatch.
Aug 28- Johnson& Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter. Earlier this year, J&J sold another of its units, Ortho-Clinical Diagnostics Inc to private-equity firm Carlyle Group for $4.15 billion.
SAN FRANCISCO, Aug 28- For a growing U.S. aging population, tracking heart health via a smartphone can mean the difference between life and death.
Aug 28- Johnson& Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury. The device, which is used to lengthen and stabilize the lower jawbone and the side of the lower jaw, is being recalled by JNJ unit DePuy Synthes as it may reverse after surgery.
Aug 20- Hackers who stole the personal data of about 4.5 million patients of hospital group Community Health Systems Inc broke into the company's computer system by exploiting the "Heartbleed" internet bug, making it the first known large-scale cyber attack using the flaw, according to a security expert.
Aug 19- Medtronic Inc Chief Executive Omar Ishrak defended his company's plan to acquire Dublin- based Covidien Plc in a so-called inversion deal, saying the medical device maker will be able to create more U.S. jobs while still paying substantial taxes once the transaction closes.
NEW YORK, Aug 19- Private equity firm Apax Partners LLP is exploring a sale of U.S. healthcare information technology company TriZetto Corp, hoping to fetch as much as $3 billion including debt, according to people familiar with the matter.
Diversified U.S. manufacturer 3 M Co and medical equipment makers CareFusion Corp and C.R. Bard Inc are among the companies exploring a potential deal for ConvaTec, the people said. CareFusion, with a market capitalization of $9 billion, and C.R. Bard, with $11.2 billion, would both be able to achieve an inversion if they use their own stock to pay for ConvaTec.
Aug 18- U.S. hospital operator Community Health Systems Inc said it suspected personal data, including patient names and addresses, of about 4.5 million people were stolen by Chinese hackers from its computer network during April and June. It did not include patient credit card or medical information, Community Health Systems said in a regulatory filing.